Renal denervation disrupts kidney nerves to lower resistant hypertension. The minimally invasive procedure, FDA-approved in 2023, offers modest benefits and is being cautiously adopted. Experts urge lifestyle changes, regular monitoring, and informed discussions to determine suitability. While not a cure, some patients, like Michael Garrity, see significant improvements.
We'll keep you updated on all new application updates and features!